chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot arm; 2 inches size redness at the arm; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot arm), INJECTION SITE ERYTHEMA (2 inches size redness at the arm) and VACCINATION SITE SWELLING (Swollen arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 11-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot arm), INJECTION SITE ERYTHEMA (2 inches size redness at the arm) and VACCINATION SITE SWELLING (Swollen arm).   At the time of the report, VACCINATION SITE WARMTH (Hot arm), INJECTION SITE ERYTHEMA (2 inches size redness at the arm) and VACCINATION SITE SWELLING (Swollen arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain
Clinical narrative: achy; tired; Felt like flu, achy and tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like flu, achy and tired), PAIN (achy) and FATIGUE (tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Flu: flu shot on 12-Jan-2021.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 12-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like flu, achy and tired). On 23-Jan-2021, the patient experienced PAIN (achy) and FATIGUE (tired).   On 24-Jan-2021, PAIN (achy) and FATIGUE (tired) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Felt like flu, achy and tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-006595 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Hypersomnia
Clinical narrative: Laid around all day yesterday; arm much sorer; 2-3 hours of chills during the night; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Laid around all day yesterday), AXILLARY PAIN (arm much sorer) and CHILLS (2-3 hours of chills during the night) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 20-Feb-2021, the patient experienced AXILLARY PAIN (arm much sorer) and CHILLS (2-3 hours of chills during the night).   On 21-Feb-2021, the patient experienced HYPERSOMNIA (Laid around all day yesterday).   On 20-Feb-2021, CHILLS (2-3 hours of chills during the night) had resolved. On 21-Feb-2021, HYPERSOMNIA (Laid around all day yesterday) had resolved.   At the time of the report, AXILLARY PAIN (arm much sorer) was resolving.      No relevant concomitant medications were reported. Treatment information was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site mass, Injection site pruritus
Clinical narrative: Large red lump at the injection site; Little itchy in the area the vaccine was administered; Chills; Felt very tired; A spontaneous report was received from a consumer concerning a 71 years old female patient who had received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some chills, felt very tired/fatigue and had a little itchy in the area the vaccine was administered/ injection site pruritus, large red lump at the injection site/injection site mass.  The patient's medical history as reported by the reporter included, the patient was allergic to aspirin and had high cholesterol. Concomitant medications used by the patient were citalopram, carbamazepine, and vitamins.   On 18 Jan 2021, prior to the onset of the events, the patient had received first of their two planned doses of mRNA-1273 (Lot number: 013-204) through unknown route on left arm for prophylaxis of COVID-19 infection.   On 18 Jan 2021, patient experienced some chills, felt very tired and had a little itchy in the area the where the vaccine was administered. On 26 Jan 2021, the patient woke up with a large red lump at the injection site and it was very very itchy. The itchiness was driving her nuts and patient consulted her pharmacist about delayed reactions to the vaccine, and pharmacist prescribed Benadryl, a Hydrocortisone cream and ice patchs, and had encouraged her to report this symptoms. On an unknown date, on the day of reporting the injection site became lighter and softer, not the big, round, hard red lump that she had a few days ago.  Treatment activities were done with diphenhydramine, hydrocortisone cream, ice patch.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events, experienced some chills, felt very tired, and had a little itchy in the area the vaccine was administered, large red lump at the injection site   were unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Musculoskeletal stiffness, Pain in extremity, Pyrexia
Clinical narrative: SORE ARM; STIFF MUSCLES; CHILLS; FEVER; HEADACHES; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM), MUSCULOSKELETAL STIFFNESS (STIFF MUSCLES), CHILLS (CHILLS), PYREXIA (FEVER) and HEADACHE (HEADACHES) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (SORE ARM), MUSCULOSKELETAL STIFFNESS (STIFF MUSCLES), CHILLS (CHILLS), PYREXIA (FEVER) and HEADACHE (HEADACHES). At the time of the report, PAIN IN EXTREMITY (SORE ARM), MUSCULOSKELETAL STIFFNESS (STIFF MUSCLES), CHILLS (CHILLS), PYREXIA (FEVER) and HEADACHE (HEADACHES) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided. No concomitant medications of the patient were reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: arm wasn't as sore; Second dose given on day 24; fever, temperature didn't get as high; headache; chills; fatigue, tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm wasn't as sore), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 24), PYREXIA (fever, temperature didn't get as high), HEADACHE (headache) and CHILLS (chills) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (experienced loss of taste, loss of smell and a fever of 100.4) in September 2020. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 24). On an unknown date, the patient experienced VACCINATION SITE PAIN (arm wasn't as sore), PYREXIA (fever, temperature didn't get as high), HEADACHE (headache), CHILLS (chills) and FATIGUE (fatigue, tiredness). On 07-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 24) had resolved. At the time of the report, VACCINATION SITE PAIN (arm wasn't as sore) outcome was unknown and PYREXIA (fever, temperature didn't get as high), HEADACHE (headache), CHILLS (chills) and FATIGUE (fatigue, tiredness) had resolved.            Concomitant medication include  Blood Pressure Medication and statin medication.  No Treatment medication was provided.   This case was linked to MOD-2021-022930 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up received 25-May-2021 which includes Outcome of the events was updated to recovered On 31-Jul-2021: Follow-up received on 31-jul-2021 in which Reporter Address was  added. Medical history, Concomitant medication and new events were added.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm wasn't as sore; Second dose given on day 24; fever, temperature didn't get as high; headache; chills; fatigue, tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm wasn't as sore), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 24), PYREXIA (fever, temperature didn't get as high), HEADACHE (headache) and CHILLS (chills) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (experienced loss of taste, loss of smell and a fever of 100.4) in September 2020. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 24). On an unknown date, the patient experienced VACCINATION SITE PAIN (arm wasn't as sore), PYREXIA (fever, temperature didn't get as high), HEADACHE (headache), CHILLS (chills) and FATIGUE (fatigue, tiredness). On 07-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 24) had resolved. At the time of the report, VACCINATION SITE PAIN (arm wasn't as sore) outcome was unknown and PYREXIA (fever, temperature didn't get as high), HEADACHE (headache), CHILLS (chills) and FATIGUE (fatigue, tiredness) had resolved.            Concomitant medication include  Blood Pressure Medication and statin medication.  No Treatment medication was provided.   This case was linked to MOD-2021-022930 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up received 25-May-2021 which includes Outcome of the events was updated to recovered On 31-Jul-2021: Follow-up received on 31-jul-2021 in which Reporter Address was  added. Medical history, Concomitant medication and new events were added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Vaccination site rash
Clinical narrative: red rash; warm to touch; A spontaneous report was received from a reporter, concerning a female patient of 78-Years - age, who received Moderna's COVID-19 vaccine and experienced red rash, warm to touch.  The patient's medical history was not provided. No relevant  Concomitant product medication was provided by reporter.  On12 -feb-2021 , prior to onset of event  patient  received their first of two planned doses of mRNA-1273 (lot number 015M20A) via intramuscular for COVID-19 infection prophylaxis.    On 22-Feb-2021,the patient experienced red rash, warm to touch . Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the events considered  was unknown at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Bad pain after getting the vaccine; This spontaneous case was reported by an other and describes the occurrence of PAIN (Bad pain after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Bad pain after getting the vaccine). At the time of the report, PAIN (Bad pain after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Listless, Pain in extremity
Clinical narrative: Immense fatigue; Arm a little sore; listless; Slept a lot; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Immense fatigue), PAIN IN EXTREMITY (Arm a little sore), LISTLESS (listless) and HYPERSOMNIA (Slept a lot) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M2DA) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced FATIGUE (Immense fatigue), PAIN IN EXTREMITY (Arm a little sore), LISTLESS (listless) and HYPERSOMNIA (Slept a lot). On 22-Feb-2021, FATIGUE (Immense fatigue), PAIN IN EXTREMITY (Arm a little sore), LISTLESS (listless) and HYPERSOMNIA (Slept a lot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol and a low dose valium
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Myalgia, SARS-CoV-2 test
Clinical narrative: Body Aches; Covid; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body Aches) and COVID-19 (Covid) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body Aches) and COVID-19 (Covid). At the time of the report, MYALGIA (Body Aches) and COVID-19 (Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Superficial vein prominence, Vaccination site pain
Clinical narrative: Swollen left arm; sore left arm; veins of the arm looked like sticking out.; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen left arm), PAIN IN EXTREMITY (sore left arm), SUPERFICIAL VEIN PROMINENCE (veins of the arm looked like sticking out.) and VACCINATION SITE PAIN (pain at the injection site) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Lactose intolerant and Allergy (liquid soap).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen left arm), PAIN IN EXTREMITY (sore left arm), SUPERFICIAL VEIN PROMINENCE (veins of the arm looked like sticking out.) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, PERIPHERAL SWELLING (Swollen left arm), PAIN IN EXTREMITY (sore left arm), SUPERFICIAL VEIN PROMINENCE (veins of the arm looked like sticking out.) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Caller got the COVID vaccine on 4-Jan-2021 and at the time had I had COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caller got the COVID vaccine on 4-Jan-2021 and at the time had I had COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 04-Jan-2021, the patient experienced COVID-19 (Caller got the COVID vaccine on 4-Jan-2021 and at the time had I had COVID-19). At the time of the report, COVID-19 (Caller got the COVID vaccine on 4-Jan-2021 and at the time had I had COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2021, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling
Clinical narrative: arm started to become red and swollen; arm started to become red and swollen; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm started to become red and swollen) and PERIPHERAL SWELLING (arm started to become red and swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030120A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced ERYTHEMA (arm started to become red and swollen) and PERIPHERAL SWELLING (arm started to become red and swollen). At the time of the report, ERYTHEMA (arm started to become red and swollen) and PERIPHERAL SWELLING (arm started to become red and swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: swollen face; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swollen face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported. ).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced SWELLING FACE (swollen face). At the time of the report, SWELLING FACE (swollen face) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: very very bad nausea; throwing up all night; A spontaneous report was received from a reporter, concerning a female patient of 40-Years - age, who received Moderna's COVID-19 vaccine and experienced very very bad nausea, throwing up all night.  The patient's medical history was not provided. No relevant  Concomitant product medication was provided by reporter.  On22 -feb-2021 , prior to onset of event  patient  received their second of two planned doses of mRNA-1273 (lot number unknown) via unknown route for COVID-19 infection prophylaxis.    On 22-Feb-2021,the patient experienced a "very very bad nausea" and has been throwing up all night. Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was not  applicable.  The outcome of the events considered  was unknown at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pruritus, Tenderness
Clinical narrative: Pain; Tenderness; Redness; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), TENDERNESS (Tenderness), ERYTHEMA (Redness) and PRURITUS (Itchiness) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 18-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN (Pain), TENDERNESS (Tenderness), ERYTHEMA (Redness) and PRURITUS (Itchiness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Pain), TENDERNESS (Tenderness), ERYTHEMA (Redness) and PRURITUS (Itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Joint swelling, Peripheral swelling, Skin reaction
Clinical narrative: arm itchy; arm red; severe headache; arm hot; delayed reaction; arm swelled; fogginess; diarrhea; joint swelling; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (fogginess), SKIN REACTION (delayed reaction), DIARRHOEA (diarrhea), JOINT SWELLING (joint swelling) and PERIPHERAL SWELLING (arm swelled) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid disorder (.). Concurrent medical conditions included Cancer and Hypertension (Medical history reported as blood pressure.). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VISION BLURRED (fogginess), DIARRHOEA (diarrhea) and JOINT SWELLING (joint swelling). On 20-Feb-2021, the patient experienced SKIN REACTION (delayed reaction), PERIPHERAL SWELLING (arm swelled), VACCINATION SITE WARMTH (arm hot) and HEADACHE (severe headache). On an unknown date, the patient experienced VACCINATION SITE REACTION (arm itchy) and VACCINATION SITE ERYTHEMA (arm red). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. On 14-Feb-2021, VISION BLURRED (fogginess), DIARRHOEA (diarrhea) and JOINT SWELLING (joint swelling) had resolved. At the time of the report, SKIN REACTION (delayed reaction), PERIPHERAL SWELLING (arm swelled), VACCINATION SITE REACTION (arm itchy), VACCINATION SITE WARMTH (arm hot), VACCINATION SITE ERYTHEMA (arm red) and HEADACHE (severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications High blood pressure medication, thyroid medication, water pill.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site reaction, Vaccination site warmth, Vision blurred
Clinical narrative: arm itchy; arm red; severe headache; arm hot; delayed reaction; arm swelled; fogginess; diarrhea; joint swelling; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (fogginess), SKIN REACTION (delayed reaction), DIARRHOEA (diarrhea), JOINT SWELLING (joint swelling) and PERIPHERAL SWELLING (arm swelled) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid disorder (.). Concurrent medical conditions included Cancer and Hypertension (Medical history reported as blood pressure.). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VISION BLURRED (fogginess), DIARRHOEA (diarrhea) and JOINT SWELLING (joint swelling). On 20-Feb-2021, the patient experienced SKIN REACTION (delayed reaction), PERIPHERAL SWELLING (arm swelled), VACCINATION SITE WARMTH (arm hot) and HEADACHE (severe headache). On an unknown date, the patient experienced VACCINATION SITE REACTION (arm itchy) and VACCINATION SITE ERYTHEMA (arm red). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. On 14-Feb-2021, VISION BLURRED (fogginess), DIARRHOEA (diarrhea) and JOINT SWELLING (joint swelling) had resolved. At the time of the report, SKIN REACTION (delayed reaction), PERIPHERAL SWELLING (arm swelled), VACCINATION SITE REACTION (arm itchy), VACCINATION SITE WARMTH (arm hot), VACCINATION SITE ERYTHEMA (arm red) and HEADACHE (severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications High blood pressure medication, thyroid medication, water pill.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: a reaction in the injection site/ is very itchy; A spontaneous report was received from a consumer/physician concerning a 72 years old, female patient who developed/experienced a reaction in the injection site, very itchy , no rash, no red.  The patient's medical history was not provided.Concomitant product use was not provided/unknown by the reporter.  On 14FEB-2021 ,prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:[016M20A]  intramuscularly in the  upper left arm for prophylaxis of COVID-19 infection.  On 21-FEB-2021 ,the patient experienced events a reaction in the injection site ,very itchy, no red ,no rash.  Treatment details include hydrochloride and a cortisone cream.  Action taken with mRNA in response to events was not reported.  On an unknown date ,the outcome of events a reaction at the injection site ,very  itchy ,no pain ,no rash was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was a little bit sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little bit sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was a little bit sore). At the time of the report, PAIN IN EXTREMITY (arm was a little bit sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  Patient put rubbing alcohol on a white tissue and applied it to the area is the treatment medication reported.   This case was linked to MOD-2021-021923 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia, Swelling
Clinical narrative: experiencing redness, swelling and tingling in the right side of the face; experiencing redness, swelling and tingling in the right side of the face; tingling in the right side of the face; This spontaneous case was reported by a health care professional and describes the occurrence of SWELLING (experiencing redness, swelling and tingling in the right side of the face), ERYTHEMA (experiencing redness, swelling and tingling in the right side of the face) and PARAESTHESIA (tingling in the right side of the face) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (experiencing redness, swelling and tingling in the right side of the face), ERYTHEMA (experiencing redness, swelling and tingling in the right side of the face) and PARAESTHESIA (tingling in the right side of the face). At the time of the report, SWELLING (experiencing redness, swelling and tingling in the right side of the face), ERYTHEMA (experiencing redness, swelling and tingling in the right side of the face) and PARAESTHESIA (tingling in the right side of the face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itch near the injection site; hardness near the injection site; pain near injection site; swelling near the injection site; red near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itch near the injection site), VACCINATION SITE INDURATION (hardness near the injection site), VACCINATION SITE PAIN (pain near injection site), VACCINATION SITE SWELLING (swelling near the injection site) and VACCINATION SITE ERYTHEMA (red near the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itch near the injection site), VACCINATION SITE INDURATION (hardness near the injection site), VACCINATION SITE PAIN (pain near injection site), VACCINATION SITE SWELLING (swelling near the injection site) and VACCINATION SITE ERYTHEMA (red near the injection site). On 22-Feb-2021, VACCINATION SITE PRURITUS (itch near the injection site), VACCINATION SITE INDURATION (hardness near the injection site) and VACCINATION SITE PAIN (pain near injection site) had resolved. At the time of the report, VACCINATION SITE SWELLING (swelling near the injection site) had not resolved and VACCINATION SITE ERYTHEMA (red near the injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  Patient put rubbing alcohol on a white tissue and applied it to the area is the treatment medication reported.   This case was linked to MOD-2021-021920 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: radiating in the top of her arm to her hand; pain at the injection arm where the vaccine was applied (R arm); This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (radiating in the top of her arm to her hand) and INJECTION SITE PAIN (pain at the injection arm where the vaccine was applied (R arm)) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (radiating in the top of her arm to her hand) and INJECTION SITE PAIN (pain at the injection arm where the vaccine was applied (R arm)). At the time of the report, PAIN IN EXTREMITY (radiating in the top of her arm to her hand) and INJECTION SITE PAIN (pain at the injection arm where the vaccine was applied (R arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event included an injection to treat the pain as per advice of her doctor and also taking some medicines like paracetamol.
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus infection) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced SINUSITIS (sinus infection). At the time of the report, SINUSITIS (sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs are not provided. No treatment.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rash macular, Scar
Clinical narrative: dot spot on back arm, another dark spot where I bend my arm; pain; scar above my elbow; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (dot spot on back arm, another dark spot where I bend my arm), MYALGIA (pain) and SCAR (scar above my elbow) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to sulfa drug) and Drug allergy (allergic to pneumovax vaccine).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (dot spot on back arm, another dark spot where I bend my arm), MYALGIA (pain) and SCAR (scar above my elbow). At the time of the report, RASH MACULAR (dot spot on back arm, another dark spot where I bend my arm), MYALGIA (pain) and SCAR (scar above my elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant  Concomitant product medication was provided by reporter. Treatment for the event included paracetmol.    Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2021: No specific follow-up information recorded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-1 test positive
Clinical narrative: Tested positive for Covid-19; A spontaneous report  was received from a consumer concerning a 70-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and was tested positive for Covid-19.  The patient's medical history, as provided by the reporter, included thyroid. Concomitant medication included thyroid for product use of unknown indication.  On 16 Feb 2021, approximately one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 011l20a) intramuscularly for prophylaxis of COVID-19 infection.   On 17 Feb 2021, the patient was tested positive for Covid-19. Lab test included SARS Cov-1 test.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event tested positive for Covid-19 was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on my back and my stomach; This spontaneous case was reported by a consumer and describes the occurrence of rash in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   No medical history information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on my back and on my stomach). At the time of the report, RASH (Rash on my back and on my stomach) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain
Clinical narrative: Pain; Did not have strength to get up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) and ASTHENIA (Did not have strength to get up) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (Pain) and ASTHENIA (Did not have strength to get up). At the time of the report, PAIN (Pain) and ASTHENIA (Did not have strength to get up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment medications provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Laziness, Myalgia, Pain in extremity, Vaccination complication
Clinical narrative: Mildly unwell; Did not feel like doing anything; The soreness was so bad, she could feel it in her bone.; Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (The soreness was so bad, she could feel it in her bone.), VACCINATION COMPLICATION (Mildly unwell), LAZINESS (Did not feel like doing anything) and PAIN IN EXTREMITY (Soreness of arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm). On 13-Feb-2021, the patient experienced MYALGIA (The soreness was so bad, she could feel it in her bone.), VACCINATION COMPLICATION (Mildly unwell) and LAZINESS (Did not feel like doing anything). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN for Pain in arm, at an unspecified dose and frequency. At the time of the report, MYALGIA (The soreness was so bad, she could feel it in her bone.), VACCINATION COMPLICATION (Mildly unwell), LAZINESS (Did not feel like doing anything) and PAIN IN EXTREMITY (Soreness of arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dysphagia, Dyspnoea, Paraesthesia oral
Clinical narrative: felt like she couldn't swallow; chest heaviness; weird sensation on her tongue; felt like it was kind of hard to breathe; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DYSPHAGIA (felt like she couldn't swallow), CHEST DISCOMFORT (chest heaviness), PARAESTHESIA ORAL (weird sensation on her tongue) and DYSPNOEA (felt like it was kind of hard to breathe) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included GERD, COPD exacerbation and Postnasal drip.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced DYSPHAGIA (felt like she couldn't swallow), CHEST DISCOMFORT (chest heaviness), PARAESTHESIA ORAL (weird sensation on her tongue) and DYSPNOEA (felt like it was kind of hard to breathe). The patient was treated with DEXAMETHASONE ongoing since an unknown date for Adverse event, at a dose of UNK dosage form; PREDNISONE (oral) for Adverse event, at a dose of UNK dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form; FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at a dose of UNK dosage form and ALBUTEROL SULFATE for Adverse event, at a dose of UNK dosage form. On 28-Jan-2021, DYSPHAGIA (felt like she couldn't swallow), CHEST DISCOMFORT (chest heaviness), PARAESTHESIA ORAL (weird sensation on her tongue) and DYSPNOEA (felt like it was kind of hard to breathe) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include medicines for blood pressure, GERD, and rescue inhaler for her COPD.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Slight dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Slight dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Slight dizziness). At the time of the report, DIZZINESS (Slight dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up received and contain significant information. Patient contact details and start date of the vaccine, second dose information updated; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness IS left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness IS left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness IS left arm). At the time of the report, PAIN IN EXTREMITY (Soreness IS left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus, Rash
Clinical narrative: arm is puffy; painful arm; arm is red; arm is very itchy; has like a rash; This spontaneous case was reported by a physician and describes the occurrence of PERIPHERAL SWELLING (arm is puffy), PAIN IN EXTREMITY (painful arm), ERYTHEMA (arm is red), PRURITUS (arm is very itchy) and RASH (has like a rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included METFORMIN, LISINOPRIL, VITAMIN D3 and SERTRALINE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (painful arm), ERYTHEMA (arm is red), PRURITUS (arm is very itchy) and RASH (has like a rash). On an unknown date, the patient experienced PERIPHERAL SWELLING (arm is puffy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm is puffy), PAIN IN EXTREMITY (painful arm), ERYTHEMA (arm is red), PRURITUS (arm is very itchy) and RASH (has like a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. In June 2021, the patient experienced PAIN IN EXTREMITY (Pain in left arm). At the time of the report, PAIN IN EXTREMITY (Pain in left arm) outcome was unknown.            No concomitant medications or treatment details reported.
Sex: U
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Four fever blisters; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Four fever blisters) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL HERPES (Four fever blisters). At the time of the report, ORAL HERPES (Four fever blisters) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-022002 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-022002:Crosslinked (MOD21-14971)